Results 1 to 10 of about 585,185 (390)
Multizonal anogenital neoplasia in women: a cohort analysis
BMC Cancer, 2021 Background There is currently a lack of information on full anogenital evaluation of women with a previous history of anogenital neoplasia. Methods Retrospective analysis of the Homerton Anogenital Neoplasia Service records from January 2012 to March ...
Andreia Albuquerque +9 more
doaj +1 more source
The Role of TGF-β in Bone Metastases
Biomolecules, 2021 Complications associated with advanced cancer are a major clinical challenge and, if associated with bone metastases, worsen the prognosis and compromise the survival of the patients.
Trupti Trivedi +3 more
doaj +1 more source
Quantifying requirements for mitochondrial apoptosis in CAR T killing of cancer cells
Cell Death and Disease, 2023 Chimeric antigen receptor (CAR) T cell therapy is an FDA-approved treatment for several hematologic malignancies, yet not all patients respond to this treatment.
Alexandra L. Pourzia +7 more
doaj +1 more source
Translational Strategies to Target Metastatic Bone Disease
Cells, 2022 Metastatic bone disease is a common and devastating complication to cancer, confounding treatments and recovery efforts and presenting a significant barrier to de-escalating the adverse outcomes associated with disease progression.
Gabriel M. Pagnotti +2 more
doaj +1 more source
Antibodies, 2022 Therapeutic monoclonal antibodies (mAbs) are an emerging and very active frontier in clinical oncology, with hundred molecules currently in use or being tested.
Virginia Guzzeloni +4 more
doaj +1 more source
Adjuvant therapy in adrenocortical carcinoma: prognostic factors and treatment options
Endocrine Oncology, 2023 Adrenocortical carcinoma (ACC) is a rare cancer with high recurrence rates and heterogeneous clinical behavior. The role of adjuvant therapy remains unclear because of the challenges in collecting high-quality data for a rare cancer.
Ruaa Al-Ward +2 more
doaj +1 more source
SAGE Open Medical Case Reports, 2020 Immune checkpoint inhibitors, such as anti-cytotoxic T-lymphocyte–associated antigen-4 and anti-programmed death-1, are a type of cancer immunotherapy approved for late-stage malignancy treatment.
Anastasia Politi +4 more
doaj +1 more source
STAR Protocols, 2022 Summary: In this protocol, we describe how to generate 3D culture surrogates of chronic lymphocytic leukemia (CLL) and multiple myeloma (MM) bone marrow microenvironments. We detail the use of culturing scaffolds populated with BM stromal cells and tumor
Daniela Belloni +6 more
doaj +1 more source
Disseminated neoplasia in blue mussels, Mytilus galloprovincialis, from the Black Sea, Romania [PDF]
, 2005 Disseminated neoplasia, also called leukemia or hemic neoplasia, has been detected in 15 species of marine bivalve mollusks worldwide. The disease is characterized by the presence of single anaplastic cells with enlarged nuclei and sometimes frequent ...
Bower +37 more
core +1 more source
Chemotherapy Associated Ovarian Failure
Frontiers in Endocrinology, 2020 As the incidence of malignancies in young adults is increasing, fertility preservation in cancer survivors arises as a major concern. Especially among female cancer patients, pregnancy rates are estimated to be 40% lower compared to women of the same age.
Davide Mauri +10 more
doaj +1 more source